Funding Opportunities

Current RFAs available through CIRM

This list will be updated periodically to reflect current funding opportunities through the California Institute for Regenerative Medicine.

To learn more about the application process, please first visit CIRM's webpage. For further guidance, please contact Trevor Johnson (UCSD Office of Contract & Grant Administration) or Jennifer Braswell, PhD.

Area

Date Updated

Grant No.

Title

Amount

Duration

PI Effort

Scope

Deadline

Start after approval

Discovery
03/21/2016
DISC 1
The Inception Award (~every 12 months)
$150K
Commensurate Time
10%
Exploratory Research with human stem, progenitor or direct reprogrammed cells
11/2016
≤120 days (8 mos. to approve)
Discovery
3/21/2016
DISC 2
The Quest Awards (~every 6 months)
$700K; $1.4M for therapeutic
24 mos.
20%
Identification of a novel candidate for translational activities
09/2016
Within 120 days of approval
Discovery
03/21/2016
DISC 3.1
The Challenge Awards (~every 6 months)
$2M
24 mos.
10%
Develop, analyze and make available useful genetic information for all lines in the CIRM iPSC bank (up to 3000)
03/30/2016
Within 120 days of approval
Translational
03/21/2016
TRAN 1
Stem cell-based therapeutic candidate
$2.5-5M
30 mos.
30%
Must lead to pre-IND meeting with IND-enabling preclinical plan
07/2016
≤ 90 days (180 days to approve)
Translational
03/21/2016
TRAN 2
Diagnostic based on stem cells, or critical for stem cell based therapy development or use (~every 6 months)
$1.2M
24 mos.
30%
Must lead to pre-IND meeting with IND-enabling preclinical plan
07/2016
≤ 90 days (180 days to approve)
Translational
03/21/2016
TRAN 3
Medical device (non-diagnostic) for a stem cell-based therapy or critical for stem cell based therapy development or use (~every 6 months)
$2M
24 mos.
30%
Must lead to pre-IDE meeting with IND-enabling preclinical plan
07/2016
≤ 90 days (180 days to approve)
Translational
03/21/2016
TRAN 4
Novel tool that addresses a critical bottleneck to the discovery or development of stem cell-based therapy (~every 6 months)
$1M
24 mos.
30%
Address critical bottleneck to discovery or development of therapy; tool not subject to FDA or CLIA regulations
07/2016
≤ 90 days (180 days to approve)
Clinical
03/21/2016
CLIN 1
Late Stage Preclinical Projects
--
--
30%
Must have completed pre-IND meeting; must lead to filing an IND/IDE ≤ 24mos.
Last business day each month
≤ 45 days (90 days to approve)
Clinical
03/21/2016
CLIN 2
Clinical Trial Stage I Projects
--
--
30%
Must have active IND/IDE
Last business day each month
≤ 45 days (90 days to approve)
Clinical
03/21/2016
CLIN 3
Supplemental Accelerating Activities
--
--
--
Activities to accelerate an ongoing clinical trial that is currently funded by CIRM
Last business day of each month
≤ 45 days (90 days to approve)
Education
10/13/2015
EDUC 1
Conference Grants
$50k for Mech 1; Mech 2 TBD
--
--
Support valuable mission-specific scientific conferences
90 days before conference (Mar 1, June 1, Sept 1, Dec 1)
60 days prior to start